Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers

British Journal of Surgery

Volumn 101, Issue 4, 2014, Pages 321-338

  Kumagai, K ^a   Rouvelas, I ^a   Tsai, J A ^a   Mariosa, D ^b   Klevebro, F ^a   Lindblad, M ^a   Ye, W ^b   Lundell, L ^a   Nilsson, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ANASTOMOSIS LEAKAGE; CHEMORADIOTHERAPY; COMPARATIVE STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS TUMOR; HEART DISEASE; HUMAN; LOWER ESOPHAGUS SPHINCTER; META ANALYSIS; MORTALITY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; SELECTION BIAS; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ANASTOMOTIC LEAK; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; HEART DISEASES; HUMANS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY TRACT DISEASES; RISK FACTORS; SELECTION BIAS;

EID: 84894228929     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9418     Document Type: Review

References (57)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. Parkin DM, Bray FI, Devesa SS,. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37: S4-S66.
3. Devesa SS, Blot WJ, Fraumeni JF Jr., Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-2053. (Pubitemid 28525384)
4. Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, et al,. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 2003; 21: 4592-4596. (Pubitemid 46594032)
5. Mariette C, Piessen G, Triboulet JP,. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007; 8: 545-553. (Pubitemid 46813024)
6. Zieren HU, Müller JM, Jacobi CA, Pichlmaier H, Müller RP, Staar S,. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study. World J Surg 1995; 19: 444-449.
7. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359: 1727-1733.
8. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al,. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366: 2074-2084.
9. Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, Barbour A, et al,. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 2011; 12: 681-692.
10. Malthaner RA, Collin S, Fenlon D,. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev 2006; (3)CD001556.
11. Kaklamanos IG, Walker GR, Ferry K, Franceschi D, Livingstone AS,. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 2003; 10: 754-761. (Pubitemid 40486875)
12. Burmeister BH, Thomas JM, Burmeister EA, Walpole ET, Harvey JA, Thomson DB, et al,. Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial. Eur J Cancer 2011; 47: 354-360.
13. Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera-Knorrenschild J, et al,. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009; 27: 851-856.
14. Song F, Loke YK, Walsh T, Glenny AM, Eastwood AJ, Altman DG,. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ 2009; 338: b1147.
15. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al,. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12. (Pubitemid 26120810)
16. European Medicines Agency. Committee for Proprietary Medicinal Products. Statistical Principles for Clinical Trials-Step 5; 1998. http://www.ema.europa. eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500002928.pdf [accessed 29 December 2013].
17. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.
18. Glenny AM, Altman DG, Song F, Sakarovitch C, Deeks JJ, D'Amico R, et al,. Indirect comparisons of competing interventions. Health Technol Assess 2005; 9: 1-134, iii-iv.
19. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
20. Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, et al,. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001; 91: 2165-2174. (Pubitemid 32476382)
21. Apinop C, Puttisak P, Preecha N,. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994; 41: 391-393. (Pubitemid 24273251)
22. Baba M, Natsugoe S, Shimada M, Nakano S, Kusano C, Fukumoto T, et al,. Prospective evaluation of preoperative chemotherapy in resectable squamous cell carcinoma of the thoracic esophagus. Dis Esophagus 2000; 13: 136-141.
23. Bagheri R, RajabiMashhadi MT, Ghazvini K, Asnaashari A, Zahediyan A, Sahebi MA,. The effect of neoadjuvant chemoradiotherapy on airway colonization and postoperative respiratory complications in patients undergoing oesophagectomy for oesophageal cancer. Interact Cardiovasc Thorac Surg 2012; 14: 725-728.
24. Boonstra JJ, Kok TC, Wijnhoven BP, van Heijl M, van Berge Henegouwen MI, Ten Kate FJ, et al,. Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial. BMC Cancer 2011; 11: 181.
25. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, et al,. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337: 161-167. (Pubitemid 27306287)
26. Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, et al,. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005; 6: 659-668. (Pubitemid 41222756)
27. Cao XF, He XT, Ji L, Xiao J, Lv J,. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma. Dis Esophagus 2009; 22: 477-481.
28. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, et al,. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339: 1979-1984. (Pubitemid 29024130)
29. Law S, Fok M, Chow S, Chu KM, Wong J,. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 1997; 114: 210-217.
30. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D, et al,. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73: 1779-1784. (Pubitemid 24101950)
31. Lee JL, Park SI, Kim SB, Jung HY, Lee GH, Kim JH, et al,. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 2004; 15: 947-954. (Pubitemid 39004352)
32. Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD,. Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma. World J Gastroenterol 2010; 16: 1649-1654.
33. Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Setoyama T, Yokomakura N, et al,. Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution. Dis Esophagus 2006; 19: 468-472. (Pubitemid 44644683)
34. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, et al,. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992; 16: 1104-1109.
35. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S,. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988; 96: 242-248.
36. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, et al,. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008; 26: 1086-1092.
37. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M,. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19: 305-313. (Pubitemid 32112841)
38. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP,. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-467. (Pubitemid 26269945)
39. Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE,. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 2009; 27: 5062-5067.
40. Kelsen DP, Winter KA, Gunderson LL, Mortimer J, Estes NC, Haller DG, et al,. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 2007; 25: 3719-3725. (Pubitemid 47372613)
41. Walsh TN, Grennell M, Mansoor S, Kelly A,. Neoadjuvant treatment of advanced stage esophageal adenocarcinoma increases survival. Dis Esophagus 2002; 15: 121-124. (Pubitemid 35264633)
42. van Heijl M, van Lanschot JJ, Koppert LB, van Berge Henegouwen MI, Muller K, Steyerberg EW, et al,. Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS). BMC Surg 2008; 8: 21.
43. Ychou M, Boige V, Pignon JP, Conroy T, Bouché O, Lebreton G, et al,. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 2011; 29: 1715-1721.
44. Schuhmacher C, Gretschel S, Lordick F, Reichardt P, Hohenberger W, Eisenberger CF, et al,. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol 2010; 28: 5210-5218.
45. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al,. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.
46. Maipang T, Vasinanukorn P, Petpichetchian C, Chamroonkul S, Geater A, Chansawwaang S, et al,. Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol 1994; 56: 191-197. (Pubitemid 24226640)
47. Schlag PM,. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. Arch Surg 1992; 127: 1446-1450.
48. Greene FL, Page DL, Fleming ID,. Esophagus. In AJCC Cancer Staging Manual (6th edn), Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, (eds). Springer: New York, 2002; 91-98.
49. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J,; Australasian Gasto-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007; 8: 226-234. (Pubitemid 46291702)
50. Jin HL, Zhu H, Ling TS, Zhang HJ, Shi RH,. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. World J Gastroenterol 2009; 15: 5983-5991.
51. Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD,. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World J Gastroenterol 2009; 15: 4962-4968.
52. Urschel JD, Vasan H,. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003; 185: 538-543. (Pubitemid 36627845)
53. Lagergren J, Bergström R, Lindgren A, Nyrén O,. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-831. (Pubitemid 29142625)
54. Boshier PR, Anderson O, Hanna GB,. Transthoracic versus transhiatal esophagectomy for the treatment of esophagogastric cancer: a meta-analysis. Ann Surg 2011; 254: 894-906.
55. Schoppmann SF, Prager G, Langer FB, Riegler FM, Kabon B, Fleischmann E, et al,. Open versus minimally invasive esophagectomy: a single-center case controlled study. Surg Endosc 2010; 24: 3044-3053.
56. Martel MK, Sahijdak WM, Ten Haken RK, Kessler ML, Turrisi AT,. Fraction size and dose parameters related to the incidence of pericardial effusions. Int J Radiat Oncol Biol Phys 1998; 40: 155-161. (Pubitemid 28027581)
57. Dindo D, Demartines N, Clavien PA,. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213. (Pubitemid 38963009)